72F fusion protein

Jump to: navigation, search

WikiDoc Resources for 72F fusion protein

Articles

Most recent articles on 72F fusion protein

Most cited articles on 72F fusion protein

Review articles on 72F fusion protein

Articles on 72F fusion protein in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 72F fusion protein

Images of 72F fusion protein

Photos of 72F fusion protein

Podcasts & MP3s on 72F fusion protein

Videos on 72F fusion protein

Evidence Based Medicine

Cochrane Collaboration on 72F fusion protein

Bandolier on 72F fusion protein

TRIP on 72F fusion protein

Clinical Trials

Ongoing Trials on 72F fusion protein at Clinical Trials.gov

Trial results on 72F fusion protein

Clinical Trials on 72F fusion protein at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 72F fusion protein

NICE Guidance on 72F fusion protein

NHS PRODIGY Guidance

FDA on 72F fusion protein

CDC on 72F fusion protein

Books

Books on 72F fusion protein

News

72F fusion protein in the news

Be alerted to news on 72F fusion protein

News trends on 72F fusion protein

Commentary

Blogs on 72F fusion protein

Definitions

Definitions of 72F fusion protein

Patient Resources / Community

Patient resources on 72F fusion protein

Discussion groups on 72F fusion protein

Patient Handouts on 72F fusion protein

Directions to Hospitals Treating 72F fusion protein

Risk calculators and risk factors for 72F fusion protein

Healthcare Provider Resources

Symptoms of 72F fusion protein

Causes & Risk Factors for 72F fusion protein

Diagnostic studies for 72F fusion protein

Treatment of 72F fusion protein

Continuing Medical Education (CME)

CME Programs on 72F fusion protein

International

72F fusion protein en Espanol

72F fusion protein en Francais

Business

72F fusion protein in the Marketplace

Patents on 72F fusion protein

Experimental / Informatics

List of terms related to 72F fusion protein

Overview

72F fusion protein is a candidate tuberculosis vaccine created by SSI. The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.Kaufmann SHE, McMichael AJ (2005). "Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis". Nature Med. 11 (4 suppl): S33&ndash, S44. doi:10.1038/nm1221. PMID 15812488. Retrieved 2006-04-30.

Related Chapters

References



Linked-in.jpg